Small Intestine Neuroendocrine Tumor
📧 Sign up to get email alerts when something new happens for Small Intestine Neuroendocrine Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Diagnostic Performances of Urine and Plasma 5-hydroxyindolacetic Acid (5HIAA) Values in Patients With Small-intestine Neuroendocrine Tumors [NA]
This clinical trial update reports on the diagnostic performance of urine and plasma 5-HIAA in patients with small intestine neuroendocrine …
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: Open-Label Surufatinib in European Patients With NET [Phase 2]
An open-label Phase 2 trial of surufatinib in European patients with neuroendocrine tumors was terminated, with results posted in 2025.
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: Microbiota and Carcinogenesis of Small-intestine Neuroendocrine Tumors
A clinical trial investigating the relationship between the microbiota and carcinogenesis in small intestine neuroendocrine tumors; recruitm…
-
CLINICAL_TRIALS trial_result · 2025-02-12Clinical Trial Update: Preoperative Imaging in Patients With Small Bowel Neuroendocrine Tumors
This clinical trial update reports on preoperative imaging in patients with small bowel neuroendocrine tumors, including those with lymph no…
-
CLINICAL_TRIALS withdrawal · 2020-02-05Clinical Trial Update: Lanreotide Combined With Telotristat Ethyl or Placebo for the First-line Treatment in Patients With Advanced Well Differentiated Small Intestinal Neuroendocrine Tumours (siNET) With Highly-functioning Carcinoid Syndrome [Phase 3]
Phase 3 trial of lanreotide with telotristat ethyl or placebo for first-line treatment in advanced well-differentiated small intestinal neur…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.